{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:30:43Z","timestamp":1793046643066,"version":"4.5.0"},"reference-count":41,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2021,10,1]]},"DOI":"10.1248\/bpb.b21-00204","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T22:10:51Z","timestamp":1633039851000},"page":"1419-1426","source":"Crossref","is-referenced-by-count":5,"title":["Amyloid Beta-Peptide 25\u201335 (A\u03b2&lt;sub&gt;25\u201335&lt;\/sub&gt;) Induces Cytotoxicity &lt;i&gt;via&lt;\/i&gt; Multiple Mechanisms: Roles of the Inhibition of Glucosylceramide Synthase by A\u03b2&lt;sub&gt;25\u201335&lt;\/sub&gt; and Its Protection by D609"],"prefix":"10.1248","volume":"44","author":[{"given":"Zhihui","family":"Tang","sequence":"first","affiliation":[{"name":"Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisei","family":"Motoyoshi","sequence":"additional","affiliation":[{"name":"Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Honda","sequence":"additional","affiliation":[{"name":"Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Murayama","sequence":"additional","affiliation":[{"name":"Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Di Scala C, Chahinian H, Yahi N, Garmy N, Fantini J. Interaction of Alzheimer\u2019s \u03b2-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation. <i>Biochemistry<\/i>, <b>53<\/b>, 4489\u20134502 (2014).","DOI":"10.1021\/bi500373k"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K, Xu HE. Amyloid beta: structure, biology and structure-based therapeutic development. <i>Acta Pharmacol. Sin.<\/i>, <b>38<\/b>, 1205\u20131235 (2017).","DOI":"10.1038\/aps.2017.28"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Smith AK, Khayat E, Lockhart C, Klimov DK. Do cholesterol and sphingomyelin change the mechanism of A\u03b2<sub>25\u201335<\/sub> peptide binding to zwitterionic bilayer? <i>J. Chem. Inf. Model.<\/i>, <b>59<\/b>, 5207\u20135217 (2019).","DOI":"10.1021\/acs.jcim.9b00763"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Hannun YA, Obeid LM. Principles of bioactive lipid signaling: lessons from sphingolipids. <i>Nat. Rev. Mol. Cell Biol.<\/i>, <b>9<\/b>, 139\u2013150 (2008).","DOI":"10.1038\/nrm2329"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hannun YA, Obeid LM. Sphingolipids and their metabolism in physiology and disease. <i>Nat. Rev. Mol. Cell Biol.<\/i>, <b>19<\/b>, 175\u2013191 (2018).","DOI":"10.1038\/nrm.2017.107"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Alessenko AV, Albi E. Exploring sphingolipid implications in neurodegeneration. <i>Front. Neurol.<\/i>, <b>11<\/b>, 437 (2020).","DOI":"10.3389\/fneur.2020.00437"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ayasolla K, Khan M, Singh AK, Singh I. Inflammatory mediator and \u03b2-amyloid (25\u201335)-induced ceramide generation and iNOS expression are inhibited by vitamin E. <i>Free Radic. Biol. Med.<\/i>, <b>37<\/b>, 325\u2013338 (2004).","DOI":"10.1016\/j.freeradbiomed.2004.04.007"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Czubowicz K, J\u0119\u015bko H, Wencel P, Lukiw WJ, Strosznajder RP. The role of ceramide and sphingosine-1-phosphate in Alzheimer\u2019s disease and other neurodegenerative disorders. <i>Mol. Neurobiol.<\/i>, <b>56<\/b>, 5436\u20135455 (2019).","DOI":"10.1007\/s12035-018-1448-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Malaplate-Armand C, Florent-B\u00e9chard S, Youssef I, Koziel V, Sponne I, Kriem B, Leininger-Muller B, Olivier JL, Oster T, Pillot T. Soluble oligomers of amyloid-\u03b2 peptide induced neuronal apoptosis by activating a cPLA<sub>2<\/sub>-dependent sphingomyelinase\u2013ceramide pathway. <i>Neurobiol. Dis.<\/i>, <b>23<\/b>, 178\u2013189 (2006).","DOI":"10.1016\/j.nbd.2006.02.010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Zeng C, Lee JT, Chen H, Chen S, Hsu CY, Xu J. Amyloid-\u03b2 peptide enhances tumor necrosis factor-\u03b1-induced iNOS through neutral sphingomyelinase\/ceramide pathway in oligodendrocytes. <i>J. Neurochem.<\/i>, <b>94<\/b>, 703\u2013712 (2005).","DOI":"10.1111\/j.1471-4159.2005.03217.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sokolova T, Zakharova IO, Furaev VV, Rychkova MP, Avrova NF. Neuroprotective effect of ganglioside GM1 on the cytotoxic action of hydrogen peroxide and amyloid \u03b2-peptide in PC12 cells. <i>Neurochem. Res.<\/i>, <b>32<\/b>, 1302\u20131313 (2007).","DOI":"10.1007\/s11064-007-9304-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Khan TK, Alkon DL. Peripheral biomarkers of Alzheimer\u2019s disease. <i>J. Alzheimers Dis.<\/i>, <b>44<\/b>, 729\u2013744 (2015).","DOI":"10.3233\/JAD-142262"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Palot\u00e1s A, K\u00e1lm\u00e1n J, Palot\u00e1s M, Kem\u00e9ny L, Janka Z, Penke B. Long-term exposition of cells to \u03b2-amyloid results in decreased intracellular calcium concentration. <i>Neurochem. Int.<\/i>, <b>42<\/b>, 543\u2013547 (2003).","DOI":"10.1016\/S0197-0186(02)00188-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Bai JZ. \u03b2-Amyloid peptides <sup>1\u201340<\/sup>\u03b2A and <sup>25\u201335<\/sup>\u03b2A suppress human amylin-mediated death of RINm5F islet \u03b2-cells with distinct actions on fibril formation. <i>Cell Biol. Int.<\/i>, <b>32<\/b>, 447\u2013455 (2008).","DOI":"10.1016\/j.cellbi.2007.12.016"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Fonseca AC, Ferreiro E, Oliveira CR, Cardoso SM, Pereira CF. Activation of the endoplasmic reticulum stress response by the amyloid-beta 1\u201340 peptide in brain endothelial cells. <i>Biochim. Biophys. Acta<\/i>, <b>1832<\/b>, 2191\u20132203 (2013).","DOI":"10.1016\/j.bbadis.2013.08.007"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Shubbar MH, Penny JI. Effect of amyloid beta on ATP-binding cassette transporter expression and activity in porcine brain microvascular endothelial cells. <i>Biochim. Biophys. Acta, Gen. Subj.<\/i>, <b>1862<\/b>, 2314\u20132322 (2018).","DOI":"10.1016\/j.bbagen.2018.07.021"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Pavliukeviciene B, Zentelyte A, Jankunec M, Valiuliene G, Talaikis M, Navakauskiene R, Niaura G, Valincius G. Amyloid \u03b2 oligomers inhibit growth of human cancer cells. <i>PLOS ONE<\/i>, <b>14<\/b>, e0221563 (2019).","DOI":"10.1371\/journal.pone.0221563"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Bu XL, Cao GQ, Shen LL, Xiang Y, Jiao SS, Liu YH, Zhu C, Zeng F, Wang QH, Wang YR, He Y, Zhou HD, Wang YJ. Serum amyloid-\u03b2 levels are increased in patients with chronic obstructive pulmonary disease. <i>Neurotox. Res.<\/i>, <b>28<\/b>, 346\u2013351 (2015).","DOI":"10.1007\/s12640-015-9552-x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Yamaji T, Hanada K. Establishment of HeLa cell mutants deficient in sphingolipid-related genes using TALENs. <i>PLOS ONE<\/i>, <b>9<\/b>, e88124 (2014).","DOI":"10.1371\/journal.pone.0088124"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Tada E, Toyomura K, Nakamura H, Sasaki H, Saito T, Kaneko M, Okuma Y, Murayama T. Activation of caramidase and ceramide kinase by vanadate <i>via<\/i> a tyrosine kinase-mediated pathway. <i>J. Pharmacol. Sci.<\/i>, <b>114<\/b>, 420\u2013432 (2010).","DOI":"10.1254\/jphs.10181FP"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hori M, Gokita M, Yasue M, Honda T, Kohama T, Mashimo M, Nakamura H, Murayama T. Down-regulation of ceramide kinase <i>via<\/i> proteasome and lysosome pathways in PC12 cells by serum withdrawal: its protection by nerve growth factor and role in exocytosis. <i>Biochim. Biophys. Acta. Mol. Cell Res.<\/i>, <b>1867<\/b>, 118714 (2020).","DOI":"10.1016\/j.bbamcr.2020.118714"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Adibhatla RM, Hatcher JF, Gusain A. Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature. <i>Neurochem. Res.<\/i>, <b>37<\/b>, 671\u2013679 (2012).","DOI":"10.1007\/s11064-011-0659-z"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Hashimoto N, Matsumoto I, Takahashi H, Ashikawa H, Nakamura H, Murayama T. Cholesterol-dependent increases in glucosylceramide synthase activity in Niemann\u2013Pick disease type C model cells: abnormal trafficking of endogenously formed ceramide metabolites by inhibition of the enzyme. <i>Neuropharmacology<\/i>, <b>110<\/b> (Pt. A), 458\u2013469 (2016).","DOI":"10.1016\/j.neuropharm.2016.08.011"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Pastukhov O, Schwalm S, Zangemeister-Wittke U, Fabbro D, Bornancin F, Japtok L, Kleuser B, Pfeilschifter J, Huwiler A. The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death. <i>Br. J. Pharmacol.<\/i>, <b>171<\/b>, 5829\u20135844 (2014).","DOI":"10.1111\/bph.12886"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Honda T, Motoyoshi K, Kasahara J, Yamagata K, Takahashi H, Nakamura H, Murayama T. Tyrosine-phosphorylation and activation of glucosylceramide synthase by v-Src: its role in survival of HeLa cells against ceramide. <i>Biochim. Biophys. Acta. Mol. Cell Biol. Lipids<\/i>, <b>1866<\/b>, 158817 (2021).","DOI":"10.1016\/j.bbalip.2020.158817"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Marks N, Berg MJ, Saito M, Saito M. Glucosylceramide synthase decrease in frontal cortex of Alzheimer brain correlates with abnormal increase in endogenous ceramides: consequences to morphology and viability on enzyme suppression in cultured primary neurons. <i>Brain Res.<\/i>, <b>1191<\/b>, 136\u2013147 (2008).","DOI":"10.1016\/j.brainres.2007.10.066"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Yang H, Xie Z, Wei L, Ding M, Wang P, Bi J. Glutathione-mimetic D609 alleviates memory deficits and reduces amyloid-\u03b2 deposition in an A\u03b2PP\/PS<sub>1<\/sub> transgenic mouse model. <i>Neuroreport<\/i>, <b>29<\/b>, 833\u2013838 (2018).","DOI":"10.1097\/WNR.0000000000001040"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Sultana R, Newman SF, Abdul HM, Cai J, Pierce WM, Klein JB, Merchant M, Butterfield DA. Protective effect of D609 against amylioid-beta<sub>1\u201342<\/sub>-induced oxidative modification of neuronal proteins: redox proteomics study. <i>J. Neurosci. Res.<\/i>, <b>84<\/b>, 409\u2013417 (2006).","DOI":"10.1002\/jnr.20876"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Lee WK, Torchalski B, Kohistani N, Th\u00e9venod F. ABCB1 protects kidney proximal tubule cells against cadmium-induced apoptosis: roles of cadmium and ceramide transport. <i>Toxicol. Sci.<\/i>, <b>121<\/b>, 343\u2013356 (2011).","DOI":"10.1093\/toxsci\/kfr071"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Wegner MS, Sch\u00f6mel N, Gruber L, \u00d6rtel SB, Kjellberg MA, Mattjus P, Kurz J, Trautmann S, Peng B, Wegner M, Kaulich M, Ahrends R, Geisslinger G, Gr\u00f6sch S. UDP-glucose ceramide glucosyltransferase activates AKT, promoted proliferation, and doxorubicin resistance in breast cancer cells. <i>Cell. Mol. Life Sci.<\/i>, <b>75<\/b>, 3393\u20133410 (2018).","DOI":"10.1007\/s00018-018-2799-7"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Shen W, Henry AG, Paumier KL, Li L, Mou K, Dunlop J, Berger Z, Hirst WD. Inhibition of glucosylceramide synthase stimulates autophagy flux in neurons. <i>J. Neurochem.<\/i>, <b>129<\/b>, 884\u2013894 (2014).","DOI":"10.1111\/jnc.12672"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Valsecchi M, Mauri L, Casellato R, Prioni S, Loberto N, Prinetti A, Chigorno V, Sonnino S. Ceramide and sphingomyelin species of fibroblasts and neurons in culture. <i>J. Lipid Res.<\/i>, <b>48<\/b>, 417\u2013424 (2007).","DOI":"10.1194\/jlr.M600344-JLR200"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Ridley CM, Thur KE, Shanahan J, Thillaiappan NB, Shen A, Uhl K, Walden CM, Rahim AA, Waddington SN, Platt FM, van der Spoel AC. \u03b2-Glucosidase 2 (GBA2) activity and imino sugar pharmacology. <i>J. Biol. Chem.<\/i>, <b>288<\/b>, 26052\u201326066 (2013).","DOI":"10.1074\/jbc.M113.463562"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Shayman JA, Larsen SD. The development and use of small molecule inhibitors of glycosphingolipid metabolism for lysosomal storage diseases. <i>J. Lipid Res.<\/i>, <b>55<\/b>, 1215\u20131225 (2014).","DOI":"10.1194\/jlr.R047167"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Nietupski JB, Pacheco JJ, Chuang WL, Maratea K, Li L, Foley J, Ashe KM, Cooper CG, Aerts JM, Copeland DP, Scheule RK, Cheng SH, Marshall J. Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann\u2013Pick C mice. <i>Mol. Genet. Metab.<\/i>, <b>105<\/b>, 621\u2013628 (2012).","DOI":"10.1016\/j.ymgme.2012.01.020"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Wang Y, Liu L, Hu W, Li G. Mechanism of soluble beta-amyloid 25\u201335 neurotoxicity in primary cultured rat cortical neurons. <i>Neurosci. Lett.<\/i>, <b>618<\/b>, 72\u201376 (2016).","DOI":"10.1016\/j.neulet.2016.02.050"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Cheng W, Chen W, Wang P, Chu J. Asiatic acid protects differentiated PC12 cells from A\u03b2<sub>25\u201335<\/sub>-induced apoptosis and tau hyperphosphorylation <i>via<\/i> regulating PI3K\/Akt\/GSK-3\u03b2 signaling. <i>Life Sci.<\/i>, <b>208<\/b>, 96\u2013101 (2018).","DOI":"10.1016\/j.lfs.2018.07.016"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Sharoar MG, Islam MI, Shahnawaz M, Shin SY, Park IS. Amyloid \u03b2 binds procaspase-9 to inhibit assembly of Apaf-1 apoptosome and intrinsic apoptosis pathway. <i>Biochim. Biophys. Acta. Mol. Cell Res.<\/i>, <b>1843<\/b>, 685\u2013693 (2014).","DOI":"10.1016\/j.bbamcr.2014.01.008"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Nakamura M, Kuroiwa N, Kono Y, Takatsuki A. Glucosylceramide synthesis inhibitors block pharmacologically induced dispersal of the Golgi and anterograde membrane flow from the endoplasmic reticulum: implication of sphingolipid metabolism in maintenance of the Golgi architecture and anterograde membrane flow. <i>Biosci. Biotechnol. Biochem.<\/i>, <b>65<\/b>, 1369\u20131378 (2001).","DOI":"10.1271\/bbb.65.1369"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Sprocati T, Ronchi P, Raimondi A, Francolini M, Borgese N. Dynamic and reversible restructuring of the ER induced by PDMP in cultured cells. <i>J. Cell Sci.<\/i>, <b>119<\/b>, 3249\u20133260 (2006).","DOI":"10.1242\/jcs.03058"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Presa N, Gomez-Larrauri A, Domingues-Herrera A, Trueba M, Gomez-Mu\u00f1oz A. Novel signaling aspects of ceramide 1-phosphate. <i>Biochim. Biophys. Acta. Mol. Cell Biol. Lipids<\/i>, <b>1865<\/b>, 158630 (2020).","DOI":"10.1016\/j.bbalip.2020.158630"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/10\/44_b21-00204\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T06:28:15Z","timestamp":1633156095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/10\/44_b21-00204\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b21-00204","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"article-number":"b21-00204"}}